Literature DB >> 19073880

The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.

Mattias K Andersson1, Mattias Enoksson, Maike Gallwitz, Lars Hellman.   

Abstract

The human chymase (HC) is a major granule constituent of mast cells (MCs) residing in the connective tissue and the sub-mucosa. Although many potential substrates have been described for this important MC enzyme, its full range of in vivo substrates has most likely not yet been identified. A major step toward a better understanding of the function of the HC is therefore to determine its extended cleavage specificity. Using a phage-displayed random nonapeptide library, we show that the HC has a rather stringent substrate recognition profile. Only aromatic amino acids (aa) are accepted in position P1, with a strong preference for Tyr and Phe over Trp. Aliphatic aa are preferred in positions P2 to P4 N-terminal of the cleaved bond. In the P1' position C-terminal of the cleaved bond, Ser is clearly over-represented and acidic aa Asp and Glu are strongly preferred in the P2' position. In P3', the small aliphatic aa Ala, Val and Gly were frequently observed. The consensus sequence, from P4 to P3': Gly/Leu/Val-Val/Ala/Leu-Ala/Val/Leu-Tyr/Phe-Ser-Asp/Glu-Ala/Val/Gly, provides an instrument for the identification of novel in vivo substrates for the HC. Interestingly, a very similar cleavage specificity was recently reported for the major chymase in mouse connective tissue mast cells (CTMCs), the beta-chymase mouse mast cell protease-4, suggesting functional homology between these two enzymes. This indicates that a rather stringent chymotryptic substrate recognition profile has been evolutionary conserved for the dominant CTMC chymase in mammals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073880     DOI: 10.1093/intimm/dxn128

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  23 in total

Review 1.  Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?

Authors:  S Heuston; N P Hyland
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

3.  Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation.

Authors:  Nicholas J Shubin; Veronika A Glukhova; Morgan Clauson; Phuong Truong; Magnus Abrink; Gunnar Pejler; Nathan J White; Gail H Deutsch; Stephen R Reeves; Tomas Vaisar; Richard G James; Adrian M Piliponsky
Journal:  J Allergy Clin Immunol       Date:  2016-05-13       Impact factor: 10.793

Review 4.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

5.  Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.

Authors:  Ananya Roy; Goutham Ganesh; Helena Sippola; Sara Bolin; Osama Sawesi; Anders Dagälv; Susan M Schlenner; Thorsten Feyerabend; Hans-Reimer Rodewald; Lena Kjellén; Lars Hellman; Magnus Åbrink
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

6.  Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris.

Authors:  Eliot T Smith; Evan T Perry; Megan B Sears; David A Johnson
Journal:  Protein Expr Purif       Date:  2014-08-12       Impact factor: 1.650

Review 7.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation.

Authors:  Jindrich Chmelar; Carlo J Oliveira; Pavlina Rezacova; Ivo M B Francischetti; Zuzana Kovarova; Gunnar Pejler; Peter Kopacek; José M C Ribeiro; Michael Mares; Jan Kopecky; Michail Kotsyfakis
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

9.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

Review 10.  Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?

Authors:  Pitchai Balakumar; Jayarami Reddy; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.